AVAI BIO, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
AVAI BIO, INC. (AVAI) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$417.91 thousand for the 12-month period ending 2025-03-31, per its 10-K filed 2025-07-08.
Financial Statements › Notes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-07-08
- AVAI BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$417.91K.
- AVAI BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$446.98K.
- AVAI BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$73.94K.
- AVAI BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $63.48K, a 2435.18% increase from fiscal 2020.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 4 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2025-03-31 | -$417.91K 10-K · filed 2025-07-08 | ||
| 2024-03-31 | -$446.98K 10-K · filed 2025-07-08 | -$466.98K 10-K · filed 2024-07-03 | |
| 2023-03-31 | -$73.94K 10-K/A · filed 2025-02-19 | ||
| 2021-03-31 | $63.48K 10-K/A · filed 2021-08-18 | $52.09K 10-K · filed 2021-07-13 | |
| 2020-03-31 | $2.50K 10-K/A · filed 2021-08-18 | ||
| 2019-03-31 | $16.43K 10-K · filed 2019-07-15 | ||
| 2018-03-31 | $155.00 10-K · filed 2019-07-15 |